Alan Armstrong sold American Tower Corp (NYSE: AMT)
Alan Armstrong (R-OK), a U.S. Senator, has disclosed 1 trade in American Tower Corp (AMT) since 2026, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Alan Armstrong sold $1,001 - $15,000 of American Tower Corp (NYSE: AMT) on March 27, 2026. Since that trade, AMT is up +6.80% against the S&P 500 up +15.04%, an outperformance of -8.24%.
Data updated
Alan Armstrong's AMT trades vs the price
AMT is up +6.80% since Alan Armstrong sold on March 27, 2026, versus +15.04% for the S&P 500.
Performance since this trade
All Alan Armstrong AMT trades
Alan Armstrong & AMT trading FAQ
Is it legal for Alan Armstrong to trade American Tower Corp (AMT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including American Tower Corp (AMT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Alan Armstrong sell AMT?
Alan Armstrong disclosed a sale of $1,001 - $15,000 of American Tower Corp (AMT) on March 27, 2026, according to public STOCK Act filings.
How has AMT performed since Alan Armstrong's trade?
Since Alan Armstrong sold AMT on March 27, 2026, the stock is up +6.80%, versus +15.04% for the S&P 500 over the same period, an outperformance of -8.24%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional AMT trades?
Quantellect tracks every disclosed congressional trade in American Tower Corp (AMT) on the American Tower Corp congressional trading page, which aggregates filings across all members of Congress.
Alan Armstrong's AMT tradesAll congressional filings for American Tower CorpAlan Armstrong's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.